Foresight Ventures VCT PLC Announces Board Appointment
FORESIGHT VENTURES VCT PLC
LEI: 213800R88MRC4Y3OIW86
The Board of Foresight Ventures VCT plc is excited to share that Dr. Andrew Mackintosh has joined as a non-executive director. His appointment follows the recent merger with Thames Ventures VCT 2 plc.
Background of Dr. Andrew Mackintosh
Dr. Mackintosh brings a wealth of knowledge and experience to Foresight Ventures. He previously served as the CEO of Oxford Instruments, a company listed on the FTSE250, exemplifying his strong leadership capabilities. Beyond his leadership roles, he has significantly contributed to the intersection of scientific innovation and investment.
A Visionary in Technology and Investment
Notably, Dr. Mackintosh authored the influential Mackintosh Report in 2021, which spearheaded the establishment of the Government Office for Technology Transfer. His ongoing advisory role within this initiative highlights his commitment to facilitating technology transfer and nurturing innovation.
Contributions to Scientific Endeavors
In addition to his numerous roles, Dr. Mackintosh currently leads the UKI2S initiative—a government-backed venture capital fund dedicated to advancing companies rooted in scientific research from the UK. This position underscores his dedication to fostering growth in innovative sectors.
Honors and Leadership Credentials
The esteemed recognition he received as a Fellow of the Royal Academy of Engineering and the Institute of Physics speaks volumes about his commitment to excellence in science and technology. Furthermore, he was honored with a CBE in the New Year's Honours for his invaluable contributions to science, technology, and enterprise development.
Role within Foresight Ventures
Following his appointment, Andrew will also serve on the Company's Committees, where his extensive experience will undoubtedly enhance the strategic direction of Foresight Ventures. His expertise in balancing investment opportunities with scientific advancements will play a vital role in achieving the Company’s goals.
Contact Information
For additional inquiries, interested parties are encouraged to contact the Company Secretary of Foresight Group LLP:
Stephen Thayer
Tel: 0203 667 8100
Investor Relations can also be reached for further details:
Andrew James
Tel: 0203 667 8181
Frequently Asked Questions
Who is Dr. Andrew Mackintosh?
Dr. Mackintosh is a seasoned executive with extensive experience in technology and investment, recently appointed as a non-executive director of Foresight Ventures.
What role did Dr. Mackintosh hold before joining Foresight Ventures?
He was previously the CEO of Oxford Instruments and chaired the Royal Society Enterprise Fund, focusing on early-stage investment in technology.
What is the significance of the Mackintosh Report?
The report led to the establishment of the Government Office for Technology Transfer, enhancing technology commercialization in the UK.
What are Dr. Mackintosh's contributions to the scientific community?
As a Fellow of the Royal Academy of Engineering, he has contributed to bridging the gap between scientific research and commercial applications.
How can I contact Foresight Ventures for more information?
You can reach out to Stephen Thayer at 0203 667 8100 or Andrew James at 0203 667 8181 for investor relations inquiries.
